FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

NCT00398931 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1099

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG: MK0217, alendronate sodium / Duration of Treatment : 5 Years
DRUG: Comparator : placebo (unspecified) /Duration of Treatment : 5 Years

Sponsor

Organon and Co